Posted on July 22, 2016
Shiseido is Officially Cleared to Start RCH-01 Trial
Replicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently that Shiseido was putting the final touches on it’s clinical trial to take place at the Tokyo Medical University Hospital and Toho University Ohasi Medical Center. Now it’s official. Have at it Shiseido, and best wishes from Follicle Thought.